EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Switching from Conventional Fibrates to Pemafibrate Improves Lipid Profiles, Liver Enzymes, Renal Function, and Fibrosis Markers in Dyslipidemic Patients with MASLD: A Multicenter Real-World Study

Takao Sato, Toshihiro Miyamoto, Ryoma Fukuoka, Kazumasa Sugimoto, Yoko Tanimoto, Takashi Nakayama, Kojiro Tanimoto, Koichiro Sugimura, Yoshihide Fujimoto, Takahiko Kiyooka, Akio Kawamura

Journal of Atherosclerosis and Thrombosis · 01.07.2026 · 33 (7) · 968-978

DOI: 10.5551/jat.66030 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Atherosclerosis and Thrombosis, erschienen am 01.07.2026. Verfasst von Takao Sato und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, IUHW Narita hospital. Hauptthemen laut MEDLINE: Benzoxazoles, Biomarkers, Butyrates, Dyslipidemias. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BenzoxazolesBiomarkersButyratesDyslipidemiasFatty LiverFibric AcidsAgedFemaleHumansMaleMiddle AgedBezafibrateFenofibrateFollow-Up StudiesHypolipidemic AgentsKidney Function TestsLipidsLiverLiver CirrhosisPrognosisRetrospective StudiesTriglycerides

Stichwörter der Autor:innen

A selective PPARα modulatorFIB-4 indexFibrateRenal function

Substanzen

(R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acidBenzoxazolesBezafibrateBiomarkersButyratesFenofibrateFibric AcidsHypolipidemic AgentsLipidsTriglycerides

Autor:innen und Institutionen

  • Department of Cardiology, IUHW Narita hospital.
  • Department of Cardiology, IUHW Atami hospital.

Zitieren

APA

Sato, T., Miyamoto, T., Fukuoka, R., Sugimoto, K., Tanimoto, Y., Nakayama, T., Tanimoto, K., Sugimura, K., Fujimoto, Y., Kiyooka, T., & Kawamura, A. (2026). Switching from Conventional Fibrates to Pemafibrate Improves Lipid Profiles, Liver Enzymes, Renal Function, and Fibrosis Markers in Dyslipidemic Patients with MASLD: A Multicenter Real-World Study. Journal of Atherosclerosis and Thrombosis, 33(7), 968-978. https://doi.org/10.5551/jat.66030

Vancouver

Sato T, Miyamoto T, Fukuoka R, Sugimoto K, Tanimoto Y, Nakayama T, et al. Switching from Conventional Fibrates to Pemafibrate Improves Lipid Profiles, Liver Enzymes, Renal Function, and Fibrosis Markers in Dyslipidemic Patients with MASLD: A Multicenter Real-World Study. Journal of Atherosclerosis and Thrombosis. 2026;33(7):968-978. doi:10.5551/jat.66030

BibTeX
@article{Sato2026,
  author = {Sato, Takao and Miyamoto, Toshihiro and Fukuoka, Ryoma and Sugimoto, Kazumasa and Tanimoto, Yoko and Nakayama, Takashi and Tanimoto, Kojiro and Sugimura, Koichiro and Fujimoto, Yoshihide and Kiyooka, Takahiko and Kawamura, Akio},
  title = {Switching from Conventional Fibrates to Pemafibrate Improves Lipid Profiles, Liver Enzymes, Renal Function, and Fibrosis Markers in Dyslipidemic Patients with MASLD: A Multicenter Real-World Study},
  journal = {Journal of Atherosclerosis and Thrombosis},
  year = {2026},
  volume = {33},
  number = {7},
  pages = {968--978},
  doi = {10.5551/jat.66030}
}
Kostenlos starten →